glp-1 receptor agonist market top selling drugs us Size & Growth Report, 2026-35 North America Glucagon-Like Peptide-1 (GLP-1)

In a study published in May, researchers used a large patient dataset to compare the NAION rate within 1 year of adults with Type 2 diabetes starting GLP-1 treatment (like Ozempic) versus those starting dipeptidyl peptidase 4 inhibitors

Some anecdotal KLOW protocols extend to about 16 weeks

Clinical context matters

BPC-157 Thymosin Beta 4 may improve nervous system health by decreasing inflammation and oxidative stress, protecting neurons, and encouraging tissue repair and cell migration

Can lead to significant weight loss, sometimes 15%20% of body weight with certain agents

Start with a small amount and use consistently